$PRTO -70% on bad news (15M O/S) Dec 13, 2016
Proteon Therapeutics Announces Top-Line Data from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with CKD
http://www.otcmarkets.com/stock/PRTO/news
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.